PixarBio
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
200 Boston Ave Ste 1875, Medford, Massac...Phone Number
(617) 803-8838Website
www.pixarbio.comRevenue
<$5 MillionIndustry
About PixarBio
Is PixarBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when PixarBio launches new products
Website visits: Recent activity has been detected on your website
Check out if PixarBio is spiking on competitors!
Funding: Get notified immidiatlly once PixarBio has new funding data
Earning: See what the market has to say on PixarBio recently announced quarterly report
PixarBio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at PixarBio
Click to see if PixarBio had a recent Job posting/layoffs
Check if PixarBio has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined PixarBio as Masked Content
Find more new buyers
Compare Similar Companies to PixarBio
Compare insights from companies similar to PixarBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
PixarBio
PixarBio financials insights
Gather financial insights about PixarBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$7.2M
PixarBio Tech Stack
A closer look at the technologies used by PixarBio
PixarBio News & Media
PixarBio Corporation Clarifies Pathways to FDA Approval for NR14 to Treat “Trigeminal Neuralgia” and Post-Surgical Pain
FORT LEE, N.J.--(BUSINESS WIRE)--PixarBio Corporation, developers of NeuroRelease™ NR14, a 14-day post-surgical pain treatment, clarifies its position on NR14 treating “Trigeminal Neuralgia” and post-surgical pain. We want to clarify any confusion with respect to our early 2016 decision to terminate the US FDA Orphan Drug Designation application process for TN. In January 2016, we had decided to prioritize NR14 with a US FDA New Drug Application (NDA) approval pathway for post-surgical pain vs.PixarBio Corporation Announces Signed Agreement with Lubrizol’s Division, Particle Sciences, to cGMP Manufacture NR14 for Clinical Trials, a 14 Day Post-Surgical Pain Treatment
SALEM, N.H.--(BUSINESS WIRE)--PixarBio Corporation developers of NeuroRelease™ NR14, a 14-day post-surgical pain treatment, announces an agreement between Particle Sciences (PSI), a Lubrizol Corporation Company, to cGMP manufacture PixarBio’s NR14 product for clinical trials. In 2018, PixarBio will be able to apply to the US FDA for fast track approval through the CDER Breakthrough Therapy designation. “Although the agreement covers our 14 day treatment, we also have a 7 and 3 day product in ou
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PixarBio
KOITOTO is a trusted online platform providing reviews and login links for official 4D lottery sites and online togel betting in Indonesia. It offers a stable system, quick access, and professional services tailored for Indonesian players. The platform features a user-friendly interface, ensuring seamless navigation and efficient account management... Read More